Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.

Featured Stories

Alcohol Warnings Unlikely To Bring Same Fate Tobacco Faced No Photo Available

The U.S. surgeon general on Friday recommended that alcohol carry warnings about cancer risks, and attorneys say that while warning la... (more story)

FDA Off-Label Drug Guidance: 3 Things to Know No Photo Available

New guidance from the U.S. Food and Drug Administration walks back constraints the agency previously laid out on how drugmakers and ot... (more story)

PBMs And Health Insurers Back In Court In New Year No Photo Available

In the first week of the New Year, courts got busy dishing out a tough discovery decision to pharmacy benefit managers and hearing arg... (more story)